Provided by Tiger Fintech (Singapore) Pte. Ltd.

PAVmed

0.6600
+0.05048.27%
Post-market: 0.66000.00000.00%19:13 EDT
Volume:306.50K
Turnover:191.12K
Market Cap:7.31M
PE:1.25
High:0.6700
Open:0.5913
Low:0.5900
Close:0.6096
Loading ...

Company Profile

Company Name:
PAVmed
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
107
Office Location:
360 Madison Avenue,25th Floor,New York,New York,United States
Zip Code:
10017
Fax:
- -
Introduction:
PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Directors

Name
Position
Lishan Aklog
Chairman and Chief Executive Officer
Michael J. Glennon
Vice Chairman and Director
Debra J. White
Director
James L. Cox
Director
Joan B. Harvey
Director
Ronald M. Sparks
Director
Timothy E. Baxter
Director

Shareholders

Name
Position
Lishan Aklog
Chairman and Chief Executive Officer
Shaun M. O'Neil
Chief Operating Officer
Dennis M. McGrath
President and Chief Financial Officer
Brian J. deGuzman
Chief Technology and Compliance Officer
Michael A. Gordon
General Counsel and Secretary